| Document |
Document Title |
|
WO/2020/112374A1 |
The compound of formula (I), compositions thereof, processes for their preparation, and their uses as pesticides.
|
|
WO/2020/107189A1 |
Pyrrolidine derivatives of formula I are used as anti-malaria agents, wherein the variables are as defined herein. Method of employing such agents in the treatment and prevention of malaria are also provided herein.
|
|
WO/2020/094363A1 |
Compounds of formula I wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
|
|
WO/2020/093163A1 |
The present disclosure relates to the composition of one or more agents, therapies, treatments, and methods of use of the agents and/or therapies and/or treatments for upregulating production of two or more antibodies, one or more bi-spe...
|
|
WO/2020/093014A1 |
Described herein are pharmaceutical compositions including in combination at least one antiparasitic drug and one antiprotozoal drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The com...
|
|
WO/2020/089815A1 |
Provided herein are STING agonists and immunoconjugates comprising STING agonists. Also disclosed are methods of making the STING agonists and immunoconjugates and methods of treating cancer using them.
|
|
WO/2020/090585A1 |
The present invention addresses the problem of providing a (hetero)arylimidazole compound which has an excellent harmful organism controlling activity, particularly an excellent insecticidal activity and/or an excellent acaricidal activi...
|
|
WO/2020/091606A1 |
The present invention relates to a composition comprising one or more capsaicinoids, or analogues or salts thereof, and acetic acid for use in prevention and treatment of infestations or infections of parasites on fish. Treatment of salm...
|
|
WO/2020/083971A2 |
The present invention relates to novel compounds of general formula (I) with A being A1 or A2, and in which T, X, Y, Ro, R1, R10 and R11 are as defined herein, methods of preparing said compounds, intermediate compounds useful for prepar...
|
|
WO/2020/084846A1 |
[4-Methoxymethyl)-2,3,6-trifluorophenyl]methyl 2,2-dimethyl-3-((Z)-1-propenyl)cyclopropanecarboxylate has an excellent controlling effect on ixodid ticks and, therefore, is usable as an active ingredient of a composition for controlling ...
|
|
WO/2020/083662A1 |
The invention relates to compounds of formula (I), wherein the variables are as defined in the specification. It also relates to the use of compounds of formula (I) as an agrochemical pesticide; to pesticidal mixtures comprising compound...
|
|
WO/2020/079427A1 |
The invention relates to fusion proteins, and to the use of fusion proteins (or genetic constructs or vectors encoding such fusion proteins) to vaccinate against viral infections. The invention extends to pharmaceutical compositions comp...
|
|
WO/2020/079198A1 |
Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts,stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
|
|
WO/2020/077284A1 |
The invention relates to a method of treating parasitic etiologies of ophthalmic diseases in the eyelash, eyelid, or cutaneous tissue surrounding the eyelash or eyelid by topically applying to the eyelash, eyelid, or cutaneous tissue sur...
|
|
WO/2020/075046A1 |
The application relates to N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)- [1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxa
zole-5- carboxamide (Compound I) fumaric acid co-crystals and X- ray amorphous complexes of Compound (I) and...
|
|
WO/2020/074672A2 |
The invention relates to the use of an antibiotic-free antimicrobial feed additive in a method of improving the health of animals and/or reducing methane production of animals. The invention also provides an antimicrobial composition whi...
|
|
WO/2020/072886A1 |
Provided are methods of administering a catechol-O-methyltransferase (COMT) inhibitor chosen from opicapone, or a pharmaceutically acceptable salt and/or isotopic variant thereof, to a patient in need thereof wherein the patient is alrea...
|
|
WO/2020/071304A1 |
The present invention addresses the problem of providing a heteroarylazole compound that has excellent pest control activity, in particular, insecticidal activity and/or miticidal activity and high safety and can be industrially advantag...
|
|
WO/2020/072343A1 |
The present invention provides a method of treating liver fluke infections in a mammal in need of such treatment comprising administering an effective amount of diamphenethide in combination with an effective amount of clorsulon.
|
|
WO/2020/068562A1 |
Methods of treating infections caused by free-living amoeba are disclosed. The methods generally include systemic administration of an effective amount of miltefosine, such as an oral or intravenous formulation, and optionally local admi...
|
|
WO/2020/061279A1 |
The invention relates to inhibitors of calcium-dependent protein kinase 1 (CDPK1) and pharmaceutical preparations thereof. The invention further relates to methods of treatment of parasitic infections, such as T. gondii, P. falciparum, C...
|
|
WO/2020/058385A1 |
The invention concerns a rinsable oily suspension of submicron colloidal mineral particles dispersed on a submicroscopic scale, the rinsable oily suspension comprising: - a lipophilic dispersing phase - a surfactant or a combination of a...
|
|
WO/2020/053365A2 |
Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
|
|
WO/2020/054712A1 |
A compound represented by formula (1), formula (2), or formula (3) or a salt thereof, or an N-oxide thereof.
|
|
WO/2020/053364A1 |
Compounds of formula I (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.
|
|
WO/2020/054821A1 |
The present invention addresses the problem of developing, by focusing on the central role of group 2 innate lymphoid cells (ILC2) in the immune system, a drug that is capable of inhibiting the activity of ILC2. The present invention has...
|
|
WO/2020/051689A1 |
The present application relates to the treatment of nematode infections. For example, the application relates to the use of compounds of Formula (III) as defined herein for treatment of a nematode infection or a disease, disorder or cond...
|
|
WO/2020/053509A1 |
The invention relates to a family of analogue compounds of squalamine for their use as a drug, in particular for treating or for preventing mycobacterial infections, in particular tuberculosis. A further aim of the present invention is n...
|
|
WO/2020/050212A1 |
The present invention addresses the problem of providing a heteroaryl azole compound that has an excellent pest controlling activity, in particular, an insecticidal activity and/or acaricidal activity, and high safety and can be industri...
|
|
WO/2020/051408A1 |
The present disclosure is directed to methods for preventing or treating helminth (e.g., filarial) diseases in animals. The methods are accomplished by administering to the animal a therapeutically effective amount of an inhibitor of UDP...
|
|
WO/2020/050403A1 |
This method for preventing muscle melting that occurs in the muscles of Salmoniformes is characterized in that a microsporidian expellant containing a benzimidazole-based compound as an active component is administered. The microsporidia...
|
|
WO/2020/047991A1 |
Use of an anti-acarid additive in daily chemical products. Diaryl lactam compounds have excellent anti-acarid effects, and can be used in applications such as anti-acarid body wash, anti-acarid facial cleaners and anti-acarid daily chemi...
|
|
WO/2020/051130A1 |
Described herein are methods and compositions for reducing transmission of Plasmodium to a female mosquito. Aspects of the invention relate to contacting to a mosquito with a Plasmodium transmission blocking compound. Another aspect of t...
|
|
WO/2020/043708A1 |
This invention relates to a kit comprising the components lactic acid, insulin and glucose, and optionally one or more components selected from a glucagon inhibitor, an alpha-beta adrenergic blocker and an antidiabetic agent, for treatin...
|
|
WO/2020/043831A1 |
The present invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof useful as inhibitors of Cyclophilins and modulators of cyclophilin-like proteins. The invention also relates to uses of said compound...
|
|
WO/2020/038821A1 |
The invention relates to glutarimide compounds of formula I, (I) wherein the variables have the meanings as defined in the specification, to compositions comprising them, to active compound combinations comprising them, and to their use ...
|
|
WO/2020/037438A1 |
The invention relates to a pharmaceutical composition with antineoplastic and antitumour action, and a method for obtaining same, wherein said composition comprises structured lipid nanoparticles that have a diameter of 0.1 nm to 100 nm,...
|
|
WO/2020/028977A1 |
The present disclosure relates to a controlled release complex of a carboxylated polymer having carboxyl groups having a degree of substitution of about 0.1 to about 1.0, forming a complex through ionic interaction with an antimalarial a...
|
|
WO/2020/024060A1 |
Provided herein are methods and compositions useful for inhibiting microbe growth. The methods can comprise contacting the microbe with an antimicrobial agent and bicarbonate. In some embodiments, provided herein are methods for treating...
|
|
WO/2020/025683A1 |
The invention relates to injectable prolonged-action compositions for use in the treatment of nail diseases, including potentially promoting the growth of the nail, or for use promoting the growth of the nail.
|
|
WO/2020/014745A1 |
The present invention provides a composition for human or animal consumption, preferably with antiviral, antibacterial, antifungal, antiprotozoal, immune boosting and/or toxin resistance activities. The composition includes a fungal extr...
|
|
WO/2020/016235A1 |
The present invention relates to compounds of formula (1a), (1b), (1c), (1d) or (1e) and pharmaceutically acceptable salts or solvates thereof for use in the treatment or prevention of fascioliasis. Some of these compounds are novel per ...
|
|
WO/2020/013147A1 |
Provided are: a benzimidazole compound represented by general formula (1) {wherein R1 represents a hydrogen atom or cyano group; R2 represents a (C1-C6)alkyl group, a (C1-C6)alkoxy(C1-C6)alkyl group, or a halo(C1-C6)alkyl group; R repres...
|
|
WO/2020/014068A1 |
A compound of formula (I), (IA) or formula (II) or a composition comprising the compound of formula (I), (IA) or formula (II) in association with a veterinarily acceptable carrier are described. A method of controlling helminths using sa...
|
|
WO/2020/012044A1 |
The invention relates to a method for preparing a nano-structured material of a silicate having a laminar, fibrilar or tubular structure with praziquantel, a compound with antiparasitic activity. Other aspects of the invention relate to ...
|
|
WO/2020/011808A1 |
A compound of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, which can be used as insecticides.
|
|
WO/2020/012406A1 |
The present invention relates to solid oral pharmaceutical compositions comprising spinosad for controlling an ectoparasite infestation on a companion animal. It provides a process for the preparation of said compositions. It also provid...
|
|
WO/2020/010398A1 |
The present invention broadly relates to stable emulsion compositions comprising allylisothiocyanate and the use thereof. The emulsion compositions may comprise water, allylisothiocyanate, one or more surfactants and an oil other than al...
|
|
WO/2020/007704A1 |
The present invention relates to novel halogen-substituted compounds, to processes for their preparation and to their use for controlling animal pests, in particular arthropods and especially insects and arachnids.
|
|
WO/2020/002593A1 |
This present application relates to compounds (and salts thereof) that are generally useful as anthelmintic agents. This invention also relates to uses of the compounds and salts to make medicaments, and treatments comprising the adminis...
|
